#BEGIN_DRUGCARD DB01987

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
154-87-0

# ChEBI_ID:
18290

# Chemical_Formula:
C12H18N4O7P2S

# Chemical_IUPAC_Name:
3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-{[(hydrogen phosphonatooxy)(hydroxy)phosphoryl]oxy}ethyl)-4-methyl-1,3-thiazol-3-ium

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
The coenzyme form of Vitamin B1 present in many animal tissues. It is a required intermediate in the pyruvate dehydrogenase complex and the ketoglutarate dehydrogenase complex. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Vitamin B Complex

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Thiamin Diphosphate

# HET_ID:
TDP

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C12H18N4O7P2S/c1-8-11(3-4-22-25(20,21)23-24(17,18)19)26-7-16(8)6-10-5-14-9(2)15-12(10)13/h5,7H,3-4,6H2,1-2H3,(H4-,13,14,15,17,18,19,20,21)

# InChI_Key:
InChIKey=AYEKOFBPNLCAJY-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00068

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1987

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
424.306

# Molecular_Weight_Mono:
424.037142664

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1N0H

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.2

# Predicted_LogS:
-3.1

# Predicted_Water_Solubility:
3.72e-01 g/l

# Primary_Accession_No:
DB01987

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
5431

# PubChem_Substance_ID:
46504577

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT03031
EXPT03093

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC1=C(CCO[P@](O)(=O)O[P@](O)([O-])=O)SC=[N+]1CC1=CN=C(C)N=C1N

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:41 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AY143338

# Drug_Target_1_GenBank_ID_Protein:
3093419

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
mdlC

# Drug_Target_1_Gene_Sequence:
>1587 bp
TCACTTCACCGGGCTTACGGTGCTTACTTCGATAAGTACCGGGCCTTTGGCAGAAAGCGC
TTCTTGTAGCGAACCCTTGAGCTGCTCAAGGTTGTCGGCTTTCAGCGCTTGGACACCATA
GCCCTTGGCGAGTGCGCGGAAGTCGATCCCTGGCACATCCAGCCCAGGAACGTTTTCTGC
TTCGAGAACGCCGGCAAACCATCGCAACGCACCGTAGGTGCCGTTGTTCATGATCACGAA
GATAGTGGGGATGTTGTACTGAGCTGCAGTCCACAACGCACTAATGCTGTAGTTCGCCGA
TCCGTCGCCAATGACGGCGATGACTTGTCGCTCGGGTTCTGCGAGTTGAACGCCAATTGC
TGCAGGCAGGGCGAAGCCCAGTCCGCCAGCTGCACAGAAGTAGTAGCTACCAGGGTTGCG
CATGTTCAGGCGCTGCCACATTTGGGCGGTCGTTGAAGTCGACTCGTTCAGGTAAATCGC
ATTCTCCGGGGCCATGTCGTTCAGTGTGTCGAACACTGTCTCTGGGTGAAGTCGGCCAGC
GTCTTGGTCAACCTTCGCGGGTTCCGGAGCTGCAGTTGGGAGCTGGCGGCTGCTCTCTTC
AACCAAGTTGGCAAGAGCGCTAGCCATCGCACCAATGTCTGCCACGATCGCATCGCCCAT
TGGCGCGCGTGCAGCTTCGAGCGGGTCGCAGGTCACCGAAATCAATCGCGTGCCAGGTTT
GAGATATTGACCTGGGTCGTATTGGTGGTAACGGAACACTGGAGCGCCGATTACCAAAAC
CACATCGTGACCTTCGAGCAGCTGAGAAATCGCTGCGATGCCAGCTGGCATCAATCCACG
GAAGCAAGGATGACGGGTAGGGAATGGGCAGCGTGGAGCGGATGGCGCAACCCAAACCGG
AGCTTTGAGGCGTTCGGCCAACATGACGCAGTCTGCGTTCGCATTTGCTGCGTCGACGTC
CGGGCCCAGGACGATCGCCGGGTTGGATGCGCTGTTGAGAGCTTTCACCAGAATATCGAG
ATCCTGGTCGTTCAGGCGTACTGATGAACTGACATGGCGATCAAAAAGGTGGTGGGACTG
AGGATCAGCATCCTTATCCCAATCGTCATATGGCACCGAAAGATAGACAGGGCCTTGTGG
CGCCATGCTTGCCATATGGATAGCCCTGCTCATCGCATGAGGGACTTCTGCTGCGCTTGC
GGGCTCGTAGCTCCATTTGACAAGTGGTCGTGGCAGGTTGGCGGCATCGACGTTGGTCAG
CAGAGCTTCAACGCCAATCATCGCCCTGGTCTGCTGGCCGGCAGTGACGATCAGCGGGGA
ATGTGAGTTCCAGGCGTTACTGAGTGCACCCATAGCATTGCCGGTACCAGCAGCAGAATG
CAGGTTAATGAAAGCCGGCTTCCGACTGGCTTGCGCATAGCCGTCTGCAATGCCCACCAC
ACACGCTTCCTGCAAAGCCAGGATGTATCGAAAGTCCTCTGGAAAGTCCTTCAAAAACGG
GAGCTCGTTCGAGCCAGGATTGCCGAAGACCGTATCGATGCCTTGACGTCGCAAGAGTTC
GTATGTGGTGCCGTGTACCGAAGCCAT

# Drug_Target_1_General_Function:
Amino acid transport and metabolism

# Drug_Target_1_General_References:
2271624	Tsou AY, Ransom SC, Gerlt JA, Buechter DD, Babbitt PC, Kenyon GL: Mandelate pathway of Pseudomonas putida: sequence relationships involving mandelate racemase, (S)-mandelate dehydrogenase, and benzoylformate decarboxylase and expression of benzoylformate decarboxylase in Escherichia coli. Biochemistry. 1990 Oct 23;29(42):9856-62.
7663351	Hasson MS, Muscate A, Henehan GT, Guidinger PF, Petsko GA, Ringe D, Kenyon GL: Purification and crystallization of benzoylformate decarboxylase. Protein Sci. 1995 May;4(5):955-9.
9665697	Hasson MS, Muscate A, McLeish MJ, Polovnikova LS, Gerlt JA, Kenyon GL, Petsko GA, Ringe D: The crystal structure of benzoylformate decarboxylase at 1.6 A resolution: diversity of catalytic residues in thiamin diphosphate-dependent enzymes. Biochemistry. 1998 Jul 14;37(28):9918-30.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2357

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
56356

# Drug_Target_1_Name:
Benzoylformate decarboxylase

# Drug_Target_1_Number_of_Residues:
528

# Drug_Target_1_PDB_ID:
1BFD

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00205	TPP_enzyme_M
PF02775	TPP_enzyme_C
PF02776	TPP_enzyme_N

# Drug_Target_1_Protein_Sequence:
>Benzoylformate decarboxylase
MASVHGTTYELLRRQGIDTVFGNPGSNELPFLKDFPEDFRYILALQEACVVGIADGYAQA
SRKPAFINLHSAAGTGNAMGALSNAWNSHSPLIVTAGQQTRAMIGVEALLTNVDAANLPR
PLVKWSYEPASAAEVPHAMSRAIHMASMAPQGPVYLSVPYDDWDKDADPQSHHLFDRHVS
SSVRLNDQDLDILVKALNSASNPAIVLGPDVDAANANADCVMLAERLKAPVWVAPSAPRC
PFPTRHPCFRGLMPAGIAAISQLLEGHDVVLVIGAPVFRYHQYDPGQYLKPGTRLISVTC
DPLEAARAPMGDAIVADIGAMASALANLVEESSRQLPTAAPEPAKVDQDAGRLHPETVFD
TLNDMAPENAIYLNESTSTTAQMWQRLNMRNPGSYYFCAAGGLGFALPAAIGVQLAEPER
QVIAVIGDGSANYSISALWTAAQYNIPTIFVIMNNGTYGALRWFAGVLEAENVPGLDVPG
IDFRALAKGYGVQALKADNLEQLKGSLQEALSAKGPVLIEVSTVSPVK

# Drug_Target_1_Reaction:
benzoylformate = benzaldehyde + CO2

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Benzoylformate = benzaldehyde + CO(2)

# Drug_Target_1_SwissProt_ID:
P20906

# Drug_Target_1_SwissProt_Name:
MDLC_PSEPU

# Drug_Target_1_Synonyms:
BFD
BFDC
EC 4.1.1.7

# Drug_Target_1_Theoretical_pI:
4.95

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
AL935262

# Drug_Target_2_GenBank_ID_Protein:
28272737

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
pox5

# Drug_Target_2_Gene_Sequence:
>1812 bp
TTAAAACCCACCCTGTCCAATTTGATGTTGCAAATCATCTAAGCCAAATTGTTTTAAATA
AGTTGAAAGTGGTTGTAAATCTTGAGCTTCATACCGTTGTTTAAATGCTTCAATATCAGC
TGCCGAACTCGTTGCCGAATCTAAACGAAGCTTTTCAGCAGGCAGTGGCCGATCTCCTGT
AATCACCGCATCAATCAGAACTGGTTCATGCTGAGCGATTGCTTTGGCTTGTTCAAAAAC
ATCAGGTAATTGCTCAATCTTATTAACTCGAAAAGCTTGCATGTGCACGCCATCGGCAAT
CTTACTAAAATCAATATCATTGAATTCAACGCCAATAAAATCATTCTGATTAGTATCTTC
CTGCTCATCTTTGATAAATCCATATTGGCAGTTGGTGAAAACAACATTAATCACTGGTAA
ATGGTATTGAACTTGCGTCGCCAAATCTTGCATGGTCATCGAAGCGCCACCATCACCAGC
CAGATTAAACACCTGCCGCTCAGGATAATTAAGTTTGGCAGCAATTGCTCCCGGAATACC
AACTCCCATCGTAGCAAATAAGTTAGAAGTAATGTGCCGATTGGATGGCGTTAATTTCAA
ATGTCGATTCGCATTCAAATTGATATCACCAACATCAATCGAATAGATTGCATCAGGCTC
CGCAATTTTATTAACCGCACGTAGCACTTGATATGCTTGTAAAGGCCCTTCCTGCTTATC
TTCTAATGAAGCTAGATAAGCCCGCCAATTTTTAACATTGGCTAAATTGGCTTGCCACCA
AGGTGTCGACTCCCGTTCAGATACCTGTGCTAAAATTGCAGCCAGCGTCTTTTGTGCATC
AGCAAGTACCGCAATATCTGTTTTATGTCGTTTACCTAACTTAGCCGGATCAATATCAAT
TTGTAAGAAATAACGCGTATTTTTAAACGCTTTGGAAACTTCTGCAAACGGATAATTATT
ACCAACAAATAAAACAACGTCAGCTTGCGCAAGTGCCTCATTCGCCGGTTTTTGTGCCAC
CCGATTAGCAGAACCCAAATAGGCTGGATAACGATCTGCGACAATCCCCTTAGCTGGATA
CGTACTCATTAATGGAATTTTCAACGTTTTACTCAATTGTTCGAGTTCTTTACCAGCCTT
ACGAGCTCCAATGCCATAGTAAATAAGTGGCCGTTCAGCTGCGAGTAAAGTCTGTGTCAA
TCTCGTCACTGCTTGAACGTCGGGTTCTGGTAATAACGGCGTTTGATAACTATTAGCGGA
AGCATACCAATCTTCAGCTGGAATCTGTTGCCATGGTAAATCGACTGGAATTTGCACAAC
CGCAACACCTTGGTGCGCATAGGCGCGTCGAATTGCTTCGTCAATAACATGTGGCAACGT
GGCAGCATTGACGGCTGTTACATTATAATCTGCAACGTCCGCATAAATCGGATTCTCATT
CATTTCTTGGAACGTATCCATGTTCATCCCAGTAGTGCCAAATTGACCAATAAGCGCTAG
AACAGGGACATGGTCTTCACGCGCATCATATAACCCATTCATAAGATGAGTGCCACCAGG
TCCCGCTGAGCCGAAGCAAACCCCGATTTTACCCGTTAGCTTAGCATCAGCAGCGGCGGC
CATTGCACCAACTTCTTCATGCCGTACTTGAATATAATGGATTCGATCCCTTTCTGCTGA
TAATGCGTCCATAATCGAATTAATTGAACCTCCAGGAATACCATACAAATGATCTACTCC
CCAAGCTTCTAAAACTTTAATAACTGCTGCACCTGCTAGTATGTTAGTTTGTTTTGTTTG
TTTCATAACCAT

# Drug_Target_2_General_Function:
Amino acid transport and metabolism

# Drug_Target_2_General_References:
12566566	Kleerebezem M, Boekhorst J, van Kranenburg R, Molenaar D, Kuipers OP, Leer R, Tarchini R, Peters SA, Sandbrink HM, Fiers MW, Stiekema W, Lankhorst RM, Bron PA, Hoffer SM, Groot MN, Kerkhoven R, de Vries M, Ursing B, de Vos WM, Siezen RJ: Complete genome sequence of Lactobacillus plantarum WCFS1. Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1990-5. Epub 2003 Feb 3.
8145244	Muller YA, Schumacher G, Rudolph R, Schulz GE: The refined structures of a stabilized mutant and of wild-type pyruvate oxidase from Lactobacillus plantarum. J Mol Biol. 1994 Apr 1;237(3):315-35.
8438155	Muller YA, Schulz GE: Structure of the thiamine- and flavin-dependent enzyme pyruvate oxidase. Science. 1993 Feb 12;259(5097):965-7.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2470

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
66112

# Drug_Target_2_Name:
Pyruvate oxidase

# Drug_Target_2_Number_of_Residues:
603

# Drug_Target_2_PDB_ID:
1Y9D

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00205	TPP_enzyme_M
PF02775	TPP_enzyme_C
PF02776	TPP_enzyme_N

# Drug_Target_2_Protein_Sequence:
>Pyruvate oxidase
MVMKQTKQTNILAGAAVIKVLEAWGVDHLYGIPGGSINSIMDALSAERDRIHYIQVRHEE
VGAMAAAADAKLTGKIGVCFGSAGPGGTHLMNGLYDAREDHVPVLALIGQFGTTGMNMDT
FQEMNENPIYADVADYNVTAVNAATLPHVIDEAIRRAYAHQGVAVVQIPVDLPWQQIPAE
DWYASANSYQTPLLPEPDVQAVTRLTQTLLAAERPLIYYGIGARKAGKELEQLSKTLKIP
LMSTYPAKGIVADRYPAYLGSANRVAQKPANEALAQADVVLFVGNNYPFAEVSKAFKNTR
YFLQIDIDPAKLGKRHKTDIAVLADAQKTLAAILAQVSERESTPWWQANLANVKNWRAYL
ASLEDKQEGPLQAYQVLRAVNKIAEPDAIYSIDVGDINLNANRHLKLTPSNRHITSNLFA
TMGVGIPGAIAAKLNYPERQVFNLAGDGGASMTMQDLATQVQYHLPVINVVFTNCQYGFI
KDEQEDTNQNDFIGVEFNDIDFSKIADGVHMQAFRVNKIEQLPDVFEQAKAIAQHEPVLI
DAVITGDRPLPAEKLRLDSATSSAADIEAFKQRYEAQDLQPLSTYLKQFGLDDLQHQIGQ
GGF

# Drug_Target_2_Reaction:
pyruvate + phosphate + O2 = acetyl phosphate + CO2 + H2O2

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Important for the aerobic growth. Decarboxylates pyruvate in four steps. The energy released is partially stored in acetyl phosphate

# Drug_Target_2_SwissProt_ID:
P37063

# Drug_Target_2_SwissProt_Name:
POXB_LACPL

# Drug_Target_2_Synonyms:
EC 1.2.3.3
POX
Pyruvic oxidase

# Drug_Target_2_Theoretical_pI:
5.24

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Nucleus and mitochondria

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
Not Available

# Drug_Target_3_GenBank_ID_Protein:
Not Available

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
Not Available

# Drug_Target_3_Gene_Sequence:
>Example: Dickerson dodecamer
CGCGAATTCGCG

# Drug_Target_3_General_Function:
Biological information storage and information transfer

# Drug_Target_3_General_References:
1234	Nadeau D, Marchand C: Change in the kinetics of sulphacetamide tissue distribution in Walker tumor-bearing rats. Drug Metab Dispos. 1975 Nov-Dec;3(6):565-76.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
874

# Drug_Target_3_Locus:
All loci

# Drug_Target_3_Molecular_Weight:
7656 (double strand)

# Drug_Target_3_Name:
DNA

# Drug_Target_3_Number_of_Residues:
0

# Drug_Target_3_PDB_ID:
1BNA

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
Not Available

# Drug_Target_3_Protein_Sequence:
Not Available

# Drug_Target_3_Reaction:
DNA + DNA polymerase + nNTP = 2 DNA + nNDP; DNA + RNA polymerase + NTP = mRNA + nNDP

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
DNA is the molecule of heredity, as it is responsible for the genetic propagation of most inherited traits. It is a polynucleic acid that carries genetic information on cell growth, division, and function. DNA consists of two long strands of nucleotides twisted into a double helix and held together by hydrogen bonds. The sequence of nucleotides determines hereditary characteristics. Each strand serves as the template for subsequent DNA replication and as a template for mRNA production, leading to protein synthesis via ribosomes.

# Drug_Target_3_SwissProt_ID:
Not Available

# Drug_Target_3_SwissProt_Name:
Not Available

# Drug_Target_3_Synonyms:
Deoxyribonucleic acid

# Drug_Target_3_Theoretical_pI:
Not Available

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Not Available

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
V01498

# Drug_Target_4_GenBank_ID_Protein:
Not Available

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
aceE

# Drug_Target_4_Gene_Sequence:
Not Available

# Drug_Target_4_General_Function:
Energy production and conversion

# Drug_Target_4_General_References:
11955070	Arjunan P, Nemeria N, Brunskill A, Chandrasekhar K, Sax M, Yan Y, Jordan F, Guest JR, Furey W: Structure of the pyruvate dehydrogenase multienzyme complex E1 component from Escherichia coli at 1.85 A resolution. Biochemistry. 2002 Apr 23;41(16):5213-21.
6343085	Stephens PE, Darlison MG, Lewis HM, Guest JR: The pyruvate dehydrogenase complex of Escherichia coli K12. Nucleotide sequence encoding the pyruvate dehydrogenase component. Eur J Biochem. 1983 Jun 1;133(1):155-62.
8202364	Fujita N, Mori H, Yura T, Ishihama A: Systematic sequencing of the Escherichia coli genome: analysis of the 2.4-4.1 min (110,917-193,643 bp) region. Nucleic Acids Res. 1994 May 11;22(9):1637-9.
8262214	Haydon DJ, Quail MA, Guest JR: A mutation causing constitutive synthesis of the pyruvate dehydrogenase complex in Escherichia coli is located within the pdhR gene. FEBS Lett. 1993 Dec 20;336(1):43-7.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
3675

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
99670

# Drug_Target_4_Name:
Pyruvate dehydrogenase E1 component

# Drug_Target_4_Number_of_Residues:
887

# Drug_Target_4_PDB_ID:
1RP7

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF00456	Transketolase_N

# Drug_Target_4_Protein_Sequence:
>Pyruvate dehydrogenase E1 component
MSERFPNDVDPIETRDWLQAIESVIREEGVERAQYLIDQLLAEARKGGVNVAAGTGISNY
INTIPVEEQPEYPGNLELERRIRSAIRWNAIMTVLRASKKDLELGGHMASFQSSATIYDV
CFNHFFRARNEQDGGDLVYFQGHISPGVYARAFLEGRLTQEQLDNFRQEVHGNGLSSYPH
PKLMPEFWQFPTVSMGLGPIGAIYQAKFLKYLEHRGLKDTSKQTVYAFLGDGEMDEPESK
GAITIATREKLDNLVFVINCNLQRLDGPVTGNGKIINELEGIFEGAGWNVIKVMWGSRWD
ELLRKDTSGKLIQLMNETVDGDYQTFKSKDGAYVREHFFGKYPETAALVADWTDEQIWAL
NRGGHDPKKIYAAFKKAQETKGKATVILAHTIKGYGMGDAAEGKNIAHQVKKMNMDGVRH
IRDRFNVPVSDADIEKLPYITFPEGSEEHTYLHAQRQKLHGYLPSRQPNFTEKLELPSLQ
DFGALLEEQSKEISTTIAFVRALNVMLKNKSIKDRLVPIIADEARTFGMEGLFRQIGIYS
PNGQQYTPQDREQVAYYKEDEKGQILQEGINELGAGCSWLAAATSYSTNNLPMIPFYIYY
SMFGFQRIGDLCWAAGDQQARGFLIGGTSGRTTLNGEGLQHEDGHSHIQSLTIPNCISYD
PAYAYEVAVIMHDGLERMYGEKQENVYYYITTLNENYHMPAMPEGAEEGIRKGIYKLETI
EGSKGKVQLLGSGSILRHVREAAEILAKDYGVGSDVYSVTSFTELARDGQDCERWNMLHP
LETPRVPYIAQVMNDAPAVASTDYMKLFAEQVRTYVPADDYRVLGTDGFGRSDSRENLRH
HFEVDASYVVVAALGELAKRGEIDKKVVADAIAKFNIDADKVNPRLA

# Drug_Target_4_Reaction:
pyruvate + [dihydrolipoyllysine-residue acetyltransferase] lipoyllysine = [dihydrolipoyllysine-residue acetyltransferase] S- $acetyldihydrolipoyllysine + CO2

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2). It contains multiple copies of three enzymatic components:pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase (E3)

# Drug_Target_4_SwissProt_ID:
P0AFG8

# Drug_Target_4_SwissProt_Name:
ODP1_ECOLI

# Drug_Target_4_Synonyms:
EC 1.2.4.1

# Drug_Target_4_Theoretical_pI:
5.42

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
Not Available

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
Y09702

# Drug_Target_5_GenBank_ID_Protein:
Not Available

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
por

# Drug_Target_5_Gene_Sequence:
>3699 bp
ATGGGAAAGAAAATGATGACGACTGATGGCAATACAGCGACAGCGCACGTGGCGTATGCC
ATGAGCGAAGTCGCCGCCATCTACCCCATCACCCCTTCCTCGACCATGGGCGAGGAGGCT
GACGACTGGGCGGCGCAAGGACGCAAGAACATCTTTGGCCAGACCCTGACCATACGCGAA
ATGCAGTCCGAGGCCGGCGCCGCCGGCGCGGTGCACGGGGCCCTGGCGGCCGGCGCCCTG
ACCACGACCTTCACGGCGTCGCAGGGTCTGCTGCTGATGATCCCCAACATGTACAAGATC
TCCGGCGAACTTCTGCCCGGCGTGTTCCACGTCACCGCCCGCGCCATCGCCGCGCACGCC
CTGTCCATCTTCGGTGACCACCAGGATATCTACGCCGCGCGCCAGACAGGCTTCGCCATG
CTCGCCTCCAGCTCGGTGCAGGAGGCCCACGACATGGCCCTGGTGGCCCACTTGGCGGCC
ATCGAGTCCAACGTGCCGTTCATGCACTTCTTCGACGGATTCCGCACCTCGCACGAAATC
CAGAAGATCGAGGTCCTGGACTACGCGGACATGGCCTCGCTGGTGAACCAGAAGGCCCTG
GCGGAATTCCGCGCCAAGTCCATGAACCCCGAGCACCCCCACGTGCGCGGCACGGCCCAG
AACCCCGACATCTACTTCCAGGGTCGCGAGGCAGCCAACCCCTACTACCTCAAGGTGCCC
GGCATCGTTGCCGAGTACATGCAGAAGGTCGCCTCCCTCACGGGCCGCAGCTACAAGCTC
TTTGACTACGTGGGTGCTCCCGACGCCGAGCGCGTCATCGTGTCCATGGGCTCCTCGTGC
GAGACCATCGAGGAGGTCATCAACCACCTCGCGGCCAAGGGCGAAAAGATCGGCCTGATC
AAGGTCCGCCTGTACAGGCCCTTCGTAAGCGAGGCCTTCTTCGCTGCTCTGCCCGCTTCG
GCCAAGGTCATCACGGTCCTCGACCGCACCAAGGAACCCGGCGCGCCCGGCGATCCGCTC
TACCTCGACGTGTGCTCGGCCTTCGTGGAGCGCGGCGAAGCCATGCCCAAGATCCTGGCC
GGCCGCTACGGCCTGGGTTCCAAGGAATTCAGCCCGGCCATGGTCAAGTCCGTGTACGAC
AACATGTCCGGCGCTAAGAAGAACCACTTCACCGTGGGCATCGAAGACGACGTGACCGGC
ACTTCGCTGCCGGTGGACAACGCCTTCGCCGACACCACGCCCAAGGGCACCATCCAGTGC
CAGTTCTGGGGCCTCGGCGCCGACGGCACTGTGGGCGCCAACAAGCAGGCCATCAAGATC
ATCGGCGACAACACGGACCTGTTTGCCCAGGGTTACTTCTCCTACGACTCCAAGAAATCG
GGCGGCATCACCATCTCGCACCTGCGCTTCGGCGAGAAGCCCATCCAGTCCACCTACCTG
GTCAACAGGGCCGACTATGTCGCCTGTCACAACCCGGCCTACGTGGGCATATACGACATC
CTCGAAGGCATCAAGGATGGCGGAACCTTCGTGCTCAACTCGCCTTGGAGCAGCCTCGAG
GACATGGACAAGCACCTGCCCTCCGGCATCAAGCGCACCATCGCGAACAAGAAGCTCAAG
TTCTACAACATCGACGCGGTGAAAATCGCCACCGATGTGGGACTGGGCGGCCGCATCAAC
ATGATCATGCAGACGGCCTTCTTCAAGCTGGCCGGAGTGCTGCCCTTCGAAAAGGCCGTG
GATCTGCTCAAGAAGTCCATCCACAAGGCCTACGGCAAAAAGGGCGAGAAGATCGTCAAG
ATGAACACCGACGCCGTGGACCAGGCCGTCACCTCCCTGCAGGAATTCAAGTATCCGGAT
TCCTGGAAGGACGCTCCCGCTGAGACCAAGGCCGAGCCCATGACGAACGAGTTCTTCAAG
AACGTCGTCAAGCCCATCCTGACCCAGCAGGGCGACAAGCTGCCGGTGAGCGCCTTCGAG
GCCGACGGCCGTTTCCCCCTCGGCACCAGCCAGTTCGAGAAGCGCGGCGTGGCCATCAAC
GTGCCGCAGTGGGTCCCCGAGAACTGCATCCAGTGCAACCAGTGCGCCTTCGTCTGTCCG
CACAGCGCCATCCTGCCCGTGCTGGCCAAGGAAGAGGAGTTGGTCGGCGCGCCGGCGAAC
TTCACGGCCCTGGAAGCCAAGGGCAAGGAGCTCAAGGGCTACAAGTTCCGCATCCAGATC
AACACCCTGGACTGCATGGGCTGCGGCAACTGCGCCGACATCTGTCCGCCCAAGGAAAAG
GCTCTGGTCATGCAGCCCCTGGATACCCAGCGCGACGCGCAGGTGCCCAACCTGGAGTAC
GCAGCGCGCATCCCGGTCAAATCCGAGGTGCTGCCGCGCGACTCGCTCAAGGGCAGCCAG
TTCCAGGAGCCTCTCATGGAATTCTCGGGCGCCTGCTCGGGCTGCGGCGAGACGCCCTAC
GTGCGCGTCATCACCCAGCTCTTCGGCGAGCGCATGTTCATTGCCAACGCCACGGGTTGC
TCGTCCATCTGGGGCGCGTCGGCTCCTTCCATGCCTTACAAGACCAACCGCCTCGGACAA
GGCCCGGCCTGGGGTAACTCCCTGTTCGAAGACGCGGCCGAATACGGCTTCGGCATGAAC
ATGTCCATGTTCGCCCGCCGCACGCATTTGGCCGATCTTGCCGCCAAGGCCCTGGAGAGC
GATGCCTCCGGCGATGTCAAGGAAGCCCTGCAGGGCTGGCTTGCCGGCAAGAACGATCCC
ATCAAGTCCAAGGAATACGGCGACAAGCTCAAGAAGCTGCTGGCTGGTCAGAAGGATGGT
CTGCTCGGACAGATCGCCGCCATGTCCGACCTGTACACCAAGAAGAGCGTGTGGATCTTC
GGTGGCGACGGCTGGGCCTACGACATCGGTTACGGCGGCCTGGACCATGTGCTCGCCTCG
GGCGAGGACGTGAACGTCTTCGTCATGGATACCGAGGTCTACTCCAACACCGGCGGCCAG
TCCTCCAAGGCAACGCCCACGGGCGCCGTGGCCAAGTTCGCGGCGGCCGGCAAGCGTACC
GGCAAGAAGGACCTGGCGCGCATGGTCATGACCTACGGCTACGTCTACGTGGCTACGGTC
TCCATGGGTTACAGCAAGCAGCAGTTCCTCAAGGTGCTCAAGGAAGCCGAAAGCTTCCCC
GGCCCCTCGCTGGTCATCGCCTATGCTACCTGCATCAACCAGGGTCTGCGCAAGGGCATG
GGCAAGAGCCAGGACGTCATGAACACCGCGGTCAAGTCCGGTTACTGGCCGCTGTTCCGC
TACGATCCGCGCTTGGCCGCCCAGGGCAAGAACCCCTTCCAGCTCGACTCCAAGGCTCCT
GACGGTTCCGTCGAGGAGTTCCTGATGGCCCAGAACCGCTTCGCCGTCCTCGATCGGTCC
TTCCCCGAGGACGCCAAGAGACTGCGCGCCCAGGTCGCTCACGAATTGGACGTGCGTTTC
AAGGAGTTGGAGCACATGGCCGCCACGAACATCTTCGAGTCCTTCGCGCCAGCGGGCGGC
AAGGCCGATGGTTCGGTGGATTTCGGCGAAGGTGCGGAGTTCTGCACGCGCGACGATACT
CCCATGATGGCCCGACCTGATTCCGGTGAGGCCTGCGACCAGAACCGCGCTGGCACGAGC
GAACAGCAGGGAGACCTCAGCAAGCGGACGAAGAAGTAG

# Drug_Target_5_General_Function:
Involved in electron carrier activity

# Drug_Target_5_General_References:
10048931	Chabriere E, Charon MH, Volbeda A, Pieulle L, Hatchikian EC, Fontecilla-Camps JC: Crystal structures of the key anaerobic enzyme pyruvate:ferredoxin oxidoreductase, free and in complex with pyruvate. Nat Struct Biol. 1999 Feb;6(2):182-90.
11752578	Chabriere E, Vernede X, Guigliarelli B, Charon MH, Hatchikian EC, Fontecilla-Camps JC: Crystal structure of the free radical intermediate of pyruvate:ferredoxin oxidoreductase. Science. 2001 Dec 21;294(5551):2559-63.
9294422	Pieulle L, Magro V, Hatchikian EC: Isolation and analysis of the gene encoding the pyruvate-ferredoxin oxidoreductase of Desulfovibrio africanus, production of the recombinant enzyme in Escherichia coli, and effect of carboxy-terminal deletions on its stability. J Bacteriol. 1997 Sep;179(18):5684-92.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
4562

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
133682

# Drug_Target_5_Name:
Pyruvate-ferredoxin oxidoreductase

# Drug_Target_5_Number_of_Residues:
1232

# Drug_Target_5_PDB_ID:
2PDA

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF00037	Fer4
PF01558	POR
PF01855	POR_N
PF02775	TPP_enzyme_C

# Drug_Target_5_Protein_Sequence:
>Pyruvate-ferredoxin oxidoreductase
MGKKMMTTDGNTATAHVAYAMSEVAAIYPITPSSTMGEEADDWAAQGRKNIFGQTLTIRE
MQSEAGAAGAVHGALAAGALTTTFTASQGLLLMIPNMYKISGELLPGVFHVTARAIAAHA
LSIFGDHQDIYAARQTGFAMLASSSVQEAHDMALVAHLAAIESNVPFMHFFDGFRTSHEI
QKIEVLDYADMASLVNQKALAEFRAKSMNPEHPHVRGTAQNPDIYFQGREAANPYYLKVP
GIVAEYMQKVASLTGRSYKLFDYVGAPDAERVIVSMGSSCETIEEVINHLAAKGEKIGLI
KVRLYRPFVSEAFFAALPASAKVITVLDRTKEPGAPGDPLYLDVCSAFVERGEAMPKILA
GRYGLGSKEFSPAMVKSVYDNMSGAKKNHFTVGIEDDVTGTSLPVDNAFADTTPKGTIQC
QFWGLGADGTVGANKQAIKIIGDNTDLFAQGYFSYDSKKSGGITISHLRFGEKPIQSTYL
VNRADYVACHNPAYVGIYDILEGIKDGGTFVLNSPWSSLEDMDKHLPSGIKRTIANKKLK
FYNIDAVKIATDVGLGGRINMIMQTAFFKLAGVLPFEKAVDLLKKSIHKAYGKKGEKIVK
MNTDAVDQAVTSLQEFKYPDSWKDAPAETKAEPMTNEFFKNVVKPILTQQGDKLPVSAFE
ADGRFPLGTSQFEKRGVAINVPQWVPENCIQCNQCAFVCPHSAILPVLAKEEELVGAPAN
FTALEAKGKELKGYKFRIQINTLDCMGCGNCADICPPKEKALVMQPLDTQRDAQVPNLEY
AARIPVKSEVLPRDSLKGSQFQEPLMEFSGACSGCGETPYVRVITQLFGERMFIANATGC
SSIWGASAPSMPYKTNRLGQGPAWGNSLFEDAAEYGFGMNMSMFARRTHLADLAAKALES
DASGDVKEALQGWLAGKNDPIKSKEYGDKLKKLLAGQKDGLLGQIAAMSDLYTKKSVWIF
GGDGWAYDIGYGGLDHVLASGEDVNVFVMDTEVYSNTGGQSSKATPTGAVAKFAAAGKRT
GKKDLARMVMTYGYVYVATVSMGYSKQQFLKVLKEAESFPGPSLVIAYATCINQGLRKGM
GKSQDVMNTAVKSGYWPLFRYDPRLAAQGKNPFQLDSKAPDGSVEEFLMAQNRFAVLDRS
FPEDAKRLRAQVAHELDVRFKELEHMAATNIFESFAPAGGKADGSVDFGEGAEFCTRDDT
PMMARPDSGEACDQNRAGTSEQQGDLSKRTKK

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
Oxidoreductase required for the transfer of electrons from pyruvate to flavodoxin, which reduces nitrogenase (By similarity)

# Drug_Target_5_SwissProt_ID:
P94692

# Drug_Target_5_SwissProt_Name:
P94692_DESAF

# Drug_Target_5_Synonyms:
Not Available

# Drug_Target_5_Theoretical_pI:
6.81

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Not Available

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
Not Available

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
D90214

# Drug_Target_6_GenBank_ID_Protein:
Not Available

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
ipdC

# Drug_Target_6_Gene_Sequence:
>1659 bp
ATGCGAACCCCATACTGCGTCGCCGATTACCTGCTGGACCGTCTTACAGATTGTGGTGCC
GATCATCTGTTTGGCGTGCCGGGCGACTATAACCTGCAGTTTCTCGACCACGTAATAGAC
AGCCCGGATATTTGTTGGGTGGGCTGTGCCAATGAGCTGAACGCATCCTATGCCGCTGAC
GGATACGCCCGATGTAAGGGCTTTGCCGCGCTACTGACCACATTCGGCGTTGGGGAGTTA
AGTGCCATGAACGGCATTGCCGGCAGCTATGCCGAGCATGTCCCGGTTTTACATATTGTG
GGGGCGCCGGGTACGGCGGCACAGCAAAGGGGAGAGTTGCTGCATCATACGTTGGGGGAT
GGGGAGTTCCGTCACTTTTATCATATGAGCGAGCCGATCACCGTCGCACAGGCGGTCCTT
ACCGAACAAAATGCCTGTTATGAAATCGACCGTGTGTTGACAACCATGCTTCGGGAACGC
CGCCCCGGTTATCTGATGTTACCCGCCGATGTGGCAAAAAAAGCCGCCACGCCGCCTGTA
AACGCTCTCACTCATAAGCAGGCTCATGCCGATAGCGCCTGCCTGAAAGCGTTCCGGGAT
GCTGCTGAGAACAAACTGGCGATGAGCAAACGTACCGCGCTGCTGGCCGACTTCCTTGTT
CTGCGCCATGGCCTGAAACATGCGCTACAGAAGTGGGTGAAAGAGGTACCGATGGCCCAT
GCCACCATGCTGATGGGGAAAGGGATATTCGACGAGCGTCAGGCGGGTTTTTACGGCACA
TACAGTGGTTCAGCCAGCACTGGCGCGGTAAAAGAGGCGATTGAAGGGGCTGACACGGTA
TTGTGTGTTGGCACGCGTTTTACCGATACCCTGACGGCCGGGTTCACGCACCAGCTTACC
CCGGCGCAGACCATTGAAGTTCAGCCGCATGCCGCACGCGTCGGGGATGTCTGGTTTACC
GGCATCCCAATGAACCAGGCGATTGAGACGCTGGTCGAACTCTGCAAACAGCACGTGCAT
GCTGGCCTTATGTCGTCATCATCCGGCGCAATACCGTTCCCGCAGCCGGACGGTTCGCTT
ACCCAGGAGAATTTCTGGAGAACGTTGCAAACCTTTATTCGCCCGGGGGACATTATCCTT
GCCGACCAGGGAACATCGGCCTTCGGCGCGATTGATCTGCGTTTACCGGCTGATGTGAAC
TTTATCGTCCAGCCGCTGTGGGGCTCGATTGGTTACACGCTGGCGGCGGCGTTTGGTGCA
CAAACCGCATGCCCGAACCGGCGCGTGATTGTGCTGACGGGGGATGGCGCTGCCCAGCTC
ACTATTCAGGAACTAGGCTCGATGCTGCGTGATAAACAGCACCCCATTATTCTGGTGCTC
AACAACGAAGGTTACACGGTTGAGAGGGCTATCCACGGGGCGGAGCAGCGGTATAACGAC
ATTGCTTTGTGGAACTGGACGCACATTCCGCAGGCGTTGAGCCTCGATCCTCAGTCTGAG
TGCTGGCGGGTCAGTGAAGCGGAACAGCTGGCGGACGTACTTGAAAAAGTGGCGCACCAC
GAGCGGCTCTCGTTGATTGAGGTGATGCTCCCGAAAGCGGATATCCCGCCGCTGCTCGGG
GCGCTTACCAAGGCTCTGGAAGCGTGTAATAACGCCTGA

# Drug_Target_6_General_Function:
Involved in magnesium ion binding

# Drug_Target_6_General_References:
2034209	Koga J, Adachi T, Hidaka H: Molecular cloning of the gene for indolepyruvate decarboxylase from Enterobacter cloacae. Mol Gen Genet. 1991 Apr;226(1-2):10-6.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
5607

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
60024

# Drug_Target_6_Name:
Indole-3-pyruvate decarboxylase

# Drug_Target_6_Number_of_Residues:
552

# Drug_Target_6_PDB_ID:
1OVM

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF00205	TPP_enzyme_M
PF02775	TPP_enzyme_C
PF02776	TPP_enzyme_N

# Drug_Target_6_Protein_Sequence:
>Indole-3-pyruvate decarboxylase
MRTPYCVADYLLDRLTDCGADHLFGVPGDYNLQFLDHVIDSPDICWVGCANELNASYAAD
GYARCKGFAALLTTFGVGELSAMNGIAGSYAEHVPVLHIVGAPGTAAQQRGELLHHTLGD
GEFRHFYHMSEPITVAQAVLTEQNACYEIDRVLTTMLRERRPGYLMLPADVAKKAATPPV
NALTHKQAHADSACLKAFRDAAENKLAMSKRTALLADFLVLRHGLKHALQKWVKEVPMAH
ATMLMGKGIFDERQAGFYGTYSGSASTGAVKEAIEGADTVLCVGTRFTDTLTAGFTHQLT
PAQTIEVQPHAARVGDVWFTGIPMNQAIETLVELCKQHVHAGLMSSSSGAIPFPQPDGSL
TQENFWRTLQTFIRPGDIILADQGTSAFGAIDLRLPADVNFIVQPLWGSIGYTLAAAFGA
QTACPNRRVIVLTGDGAAQLTIQELGSMLRDKQHPIILVLNNEGYTVERAIHGAEQRYND
IALWNWTHIPQALSLDPQSECWRVSEAEQLADVLEKVAHHERLSLIEVMLPKADIPPLLG
ALTKALEACNNA

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
3-(indol-3-yl)pyruvate = 2-(indol-3- yl)acetaldehyde + CO(2)

# Drug_Target_6_SwissProt_ID:
P23234

# Drug_Target_6_SwissProt_Name:
DCIP_ENTCL

# Drug_Target_6_Synonyms:
EC 4.1.1.74
Indolepyruvate decarboxylase

# Drug_Target_6_Theoretical_pI:
6.03

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Not Available

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
Not Available

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
U87786

# Drug_Target_7_GenBank_ID_Protein:
Not Available

# Drug_Target_7_GeneCard_ID:
Not Available

# Drug_Target_7_Gene_Name:
Not Available

# Drug_Target_7_Gene_Sequence:
>1722 bp
ATGTCCCGTGTATCGACCGCCCCCAGCGGCAAGCCTACCGCCGCTCACGCCCTCCTGTCA
CGGTTGCGTGATCACGGTGTGGGGAAGGTGTTTGGGGTTGTCGGCCGAGAGGCCGCGTCG
ATTCTCTTCGACGAGGTCGAGGGGATCGACTTCGTTCTGACCCGCCACGAGTTCACCGCG
GGTGTCGCCGCTGATGTCCTCGCGCGGATCACCGGTCGCCCCCAGGCGTGCTGGGCCACC
CTGGGCCCCGGTATGACCAACCTCTCCACCGGTATCGCCACGTCCGTCCTGGACCGCTCG
CCGGTCATCGCGCTCGCCGCGCAGTCGGAGTCGCACGACATCTTCCCGAACGACACCCAC
CAGTGCCTGGACTCGGTGGCGATCGTCGCCCCGATGTCCAAGTACGCCGTGGAGCTCCAG
CGGCCCCACGAGATCACCGACCTCGTCGACTCCGCCGTGAACGCGGCCATGACCGAGCCG
GTCGGGCCCTCCTTCATCTCCCTCCCGGTGGACCTGCTCGGCTCCTCCGAGGGCATCGAC
ACCACCGTCCCCAACCCGCCGGCGAACACCCCGGCGAAACCGGTCGGCGTCGTCGCCGAC
GGCTGGCAGAAGGCCGCCGACCAGGCCGCCGCCCTGCTCGCCGAGGCCAAGCACCCGGTG
CTCGTCGTCGGAGCGGCCGCGATCCGCTCGGGCGCCGTCCCGGCGATCCGCGCCCTGGCC
GAGCGCCTGAACATCCCGGTCATCACGACCTACATCGCCAAGGGTGTCCTGCCGGTCGGC
CACGAGCTGAACTACGGCGCCGTCACCGGCTACATGGACGGCATCCTCAACTTCCCGGCG
CTCCAGACCATGTTCGCCCCGGTGGACCTCGTCCTCACCGTCGGCTACGACTACGCCGAG
GACCTGCGCCCGTCCATGTGGCAGAAGGGCATCGAGAAGAAGACCGTCCGTATCTCCCCG
ACGGTCAACCCGATCCCCCGGGTCTACCGGCCCGACGTCGACGTCGTCACCGACGTCCTC
GCCTTCGTGGAGCACTTCGAGACCGCGACCGCCTCCTTCGGGGCCAAGCAGCGCCACGAC
ATCGAGCCGCTGCGCGCCCGGATCGCGGAGTTCCTGGCCGACCCGGAGACCTACGAGGAC
GGCATGCGCGTCCACCAGGTCATCGACTCCATGAACACCGTCATGGAGGAGGCCGCCGAG
CCCGGCGAGGGCACGATCGTCTCCGACATCGGCTTCTTCCGTCACTACGGTGTGCTCTTC
GCCCGCGCCGACCAGCCCTTCGGCTTCCTCACCTCGGCGGGCTGCTCCAGCTTCGGCTAC
GGCATCCCCGCCGCCATCGGCGCCCAGATGGCCCGCCCGGACCAGCCGACCTTCCTCATC
GCGGGTGACGGCGGCTTCCACTCCAACAGCTCCGACCTGGAGACCATCGCCCGGCTCAAC
CTGCCGATCGTGACCGTCGTCGTCAACAACGACACCAACGGCCTGATCGAGCTGTACCAG
AACATCGGTCACCACCGCAGCCACGACCCGGCGGTCAAGTTCGGCGGCGTCGACTTCGTC
GCGCTCGCCGAGGCCAACGGTGTCGACGCCACCCGCGCCACCAACCGCGAGGAGCTGCTC
GCGGCCCTGCGCAAGGGTGCCGAGCTGGGTCGTCCGTTCCTCATCGAGGTCCCGGTCAAC
TACGACTTCCAGCCGGGCGGCTTCGGCGCCCTGAGCATCTGA

# Drug_Target_7_General_Function:
Involved in magnesium ion binding

# Drug_Target_7_General_References:
10681345	Jensen SE, Elder KJ, Aidoo KA, Paradkar AS: Enzymes catalyzing the early steps of clavulanic acid biosynthesis are encoded by two sets of paralogous genes in Streptomyces clavuligerus. Antimicrob Agents Chemother. 2000 Mar;44(3):720-6.
8088547	Aidoo KA, Wong A, Alexander DC, Rittammer RA, Jensen SE: Cloning, sequencing and disruption of a gene from Streptomyces clavuligerus involved in clavulanic acid biosynthesis. Gene. 1994 Sep 15;147(1):41-6.
8892828	Paradkar AS, Aidoo KA, Wong A, Jensen SE: Molecular analysis of a beta-lactam resistance gene encoded within the cephamycin gene cluster of Streptomyces clavuligerus. J Bacteriol. 1996 Nov;178(21):6266-74.
9515708	Paradkar AS, Aidoo KA, Jensen SE: A pathway-specific transcriptional activator regulates late steps of clavulanic acid biosynthesis in Streptomyces clavuligerus. Mol Microbiol. 1998 Feb;27(4):831-43.

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
5608

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
60908

# Drug_Target_7_Name:
Carboxyethylarginine synthase

# Drug_Target_7_Number_of_Residues:
573

# Drug_Target_7_PDB_ID:
1UPC

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF00205	TPP_enzyme_M
PF02775	TPP_enzyme_C
PF02776	TPP_enzyme_N

# Drug_Target_7_Protein_Sequence:
>Carboxyethylarginine synthase
MSRVSTAPSGKPTAAHALLSRLRDHGVGKVFGVVGREAASILFDEVEGIDFVLTRHEFTA
GVAADVLARITGRPQACWATLGPGMTNLSTGIATSVLDRSPVIALAAQSESHDIFPNDTH
QCLDSVAIVAPMSKYAVELQRPHEITDLVDSAVNAAMTEPVGPSFISLPVDLLGSSEGID
TTVPNPPANTPAKPVGVVADGWQKAADQAAALLAEAKHPVLVVGAAAIRSGAVPAIRALA
ERLNIPVITTYIAKGVLPVGHELNYGAVTGYMDGILNFPALQTMFAPVDLVLTVGYDYAE
DLRPSMWQKGIEKKTVRISPTVNPIPRVYRPDVDVVTDVLAFVEHFETATASFGAKQRHD
IEPLRARIAEFLADPETYEDGMRVHQVIDSMNTVMEEAAEPGEGTIVSDIGFFRHYGVLF
ARADQPFGFLTSAGCSSFGYGIPAAIGAQMARPDQPTFLIAGDGGFHSNSSDLETIARLN
LPIVTVVVNNDTNGLIELYQNIGHHRSHDPAVKFGGVDFVALAEANGVDATRATNREELL
AALRKGAELGRPFLIEVPVNYDFQPGGFGALSI

# Drug_Target_7_Reaction:
Not Available

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
Not Available

# Drug_Target_7_SwissProt_ID:
Q9LCV9

# Drug_Target_7_SwissProt_Name:
Q9LCV9_STRCL

# Drug_Target_7_Synonyms:
Not Available

# Drug_Target_7_Theoretical_pI:
4.85

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Not Available

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
Not Available

# Drug_Target_8_Essentiality:
Non-Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
X68025

# Drug_Target_8_GenBank_ID_Protein:
Not Available

# Drug_Target_8_GeneCard_ID:
Not Available

# Drug_Target_8_Gene_Name:
tktA

# Drug_Target_8_Gene_Sequence:
>1995 bp
ATGTCCTCACGTAAAGAGCTTGCCAATGCTATTCGTGCGCTGAGCATGGACGCAGTACAG
AAAGCCAAATCCGGTCACCCGGGGGCCCCTATGGGTATGGCTGACATTGCCGAAGTCCTG
TGGCGTGATTTCCTGAAACACAACCCGCAGAATCCGTCCTGGGCTGACCGTGACCGCTTC
GTGCTGTCCAACGGCCACGGCTCCATGCTGATCTACAGCCTGCTGCACCTCACCGGTTAC
GATCTGCCGATGGAAGAACTGAAAAACTTCCGTCAGCTGCACTCTAAAACTCCGGGTCAC
CCGGAAAGTGGGGTTACACCGCTGGGTGTGGAAACCACCACCGGTCCGCTGGGTCAGGGT
ATTGCCAACGCAGTCGGTATGGCGATTGCAGAAAAAACGCTGGCGGCGCAGTTTAACCGT
CCGGGCCACGACATTGTCGACCACTACACCTACGCCTTCATGGGCGACGGCTGCATGATG
GAAGGCATCTCCCACGAAGTTTGCTCTCTGGCGGGTACGCTGAAGCTGGGTAAACTGATT
GCATTCTACGATGACAACGGTATTTCTATCGATGGTCACGTTGAAGGCTGGTTCACCGAC
GACACCGCAATGCGTTTCGAAGCTTACGGCTGGCACGTTATTCGCGACATCGACGGTCAT
GACGCGGCATCTATCAAACGCGCAGTAGAAGAAGCGCGCGCAGTGACTGACAAACCTTCC
CTGCTGATGTGCAAAACCATCATCGGTTTCGGTTCCCCGAACAAAGCCGGTACCCACGAC
TCCCACGGTGCGCCGCTGGGCGACGCTGAAATTGCCCTGACCCGCGAACAACTGGGCTGG
AAATATGCGCCGTTCGAAATCCCGTCTGAAATCTATGCTCAGTGGGATGCGAAAGAAGCA
GGCCAGGCGAAAGAATCCGCATGGAACGAGAAATTCGCTGCTTACGCGAAAGCTTATCCG
CAGGAAGCCGCTGAATTTACCCGCCGTATGAAAGGCGAAATGCCGTCTGACTTCGACGCT
AAAGCGAAAGAGTTCATCGCTAAACTGCAGGCTAATCCGGCGAAAATCGCCAGCCGTAAA
GCGTCTCAGAATGCTATCGAAGCGTTCGGTCCGCTGTTGCCGGAATTCCTCGGCGGTTCT
GCTGACCTGGCGCCGTCTAACCTGACCCTGTGGTCTGGTTCTAAAGCAATCAACGAAGAT
GCTGCGGGTAACTACATCCACTACGGTGTTCGCGAGTTCGGTATGACCGCGATTGCTAAC
GGTATCTCCCTGCACGGTGGCTTCCTGCCGTACACCTCCACCTTCCTGATGTTCGTGGAA
TACGCACGTAACGCCGTACGTATGGCTGCGCTGATGAAACAGCGTCAGGTGATGGTTTAC
ACCCACGACTCCATCGGTCTGGGCGAAGACGGGCCGACTCACCAGCCGGTTGAGCAGGTC
GCTTCTCTGCGCGTAACCCCGAACATGTCTACATGGCGTCCGTGTGACCAGGTTGAATCC
GCGGTCGCGTGGAAATACGGTGTTGAGCGTCAGGACGGCCCGACCGCACTGATCCTCTCC
CGTCAGAACCTGGCGCAGCAGGAACGAACTGAAGAGCAACTGGCAAACATCGCGCGCGGT
GGTTATGTGCTGAAAGACTGCGCCGGTCAGCCGGAACTGATTTTCATCGCTACCGGTTCA
GAAGTTGAACTGGCTGTTGCTGCCTACGAAAAACTGACTGCCGAAGGCGTGAAAGCGCGC
GTGGTGTCCATGTCGTCTACCGACGCATTTGACAAGCAGGATGCTGCTTACCGTGAATCC
GTACTGCCGAAAGCGGTTACTGCACGCGTTGCTGTAGAAGCGGGTATTGCTGACTACTGG
TACAAGTATGTTGGCCTGAACGGTGCTATCGTCGGTATGACCACCTTCGGTGAATCTGCT
CCGGCAGAGCTGCTGTTTGAAGAGTTCGGCTTCACTGTTGATAACGTTGTTGCGAAAGCA
AAAGAACTGCTGTAA

# Drug_Target_8_General_Function:
Involved in transketolase activity

# Drug_Target_8_General_References:
2153656	Szumanski MB, Boyle SM: Analysis and sequence of the speB gene encoding agmatine ureohydrolase, a putrescine biosynthetic enzyme in Escherichia coli. J Bacteriol. 1990 Feb;172(2):538-47.
8241274	Sprenger GA: Nucleotide sequence of the Escherichia coli K-12 transketolase (tkt) gene. Biochim Biophys Acta. 1993 Nov 16;1216(2):307-10.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_8_HGNC_ID:
Not Available

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
5610

# Drug_Target_8_Locus:
Not Available

# Drug_Target_8_Molecular_Weight:
72212

# Drug_Target_8_Name:
Transketolase 1

# Drug_Target_8_Number_of_Residues:
663

# Drug_Target_8_PDB_ID:
1QGD

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
PF00456	Transketolase_N
PF02779	Transket_pyr
PF02780	Transketolase_C

# Drug_Target_8_Protein_Sequence:
>Transketolase 1
MSSRKELANAIRALSMDAVQKAKSGHPGAPMGMADIAEVLWRDFLKHNPQNPSWADRDRF
VLSNGHGSMLIYSLLHLTGYDLPMEELKNFRQLHSKTPGHPEVGYTAGVETTTGPLGQGI
ANAVGMAIAEKTLAAQFNRPGHDIVDHYTYAFMGDGCMMEGISHEVCSLAGTLKLGKLIA
FYDDNGISIDGHVEGWFTDDTAMRFEAYGWHVIRDIDGHDAASIKRAVEEARAVTDKPSL
LMCKTIIGFGSPNKAGTHDSHGAPLGDAEIALTREQLGWKYAPFEIPSEIYAQWDAKEAG
QAKESAWNEKFAAYAKAYPQEAAEFTRRMKGEMPSDFDAKAKEFIAKLQANPAKIASRKA
SQNAIEAFGPLLPEFLGGSADLAPSNLTLWSGSKAINEDAAGNYIHYGVREFGMTAIANG
ISLHGGFLPYTSTFLMFVEYARNAVRMAALMKQRQVMVYTHDSIGLGEDGPTHQPVEQVA
SLRVTPNMSTWRPCDQVESAVAWKYGVERQDGPTALILSRQNLAQQERTEEQLANIARGG
YVLKDCAGQPELIFIATGSEVELAVAAYEKLTAEGVKARVVSMPSTDAFDKQDAAYRESV
LPKAVTARVAVEAGIADYWYKYVGLNGAIVGMTTFGESAPAELLFEEFGFTVDNVVAKAK
ELL

# Drug_Target_8_Reaction:
Not Available

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
Sedoheptulose 7-phosphate + D-glyceraldehyde 3-phosphate = D-ribose 5-phosphate + D-xylulose 5-phosphate

# Drug_Target_8_SwissProt_ID:
P27302

# Drug_Target_8_SwissProt_Name:
TKT1_ECOLI

# Drug_Target_8_Synonyms:
EC 2.2.1.1
TK 1

# Drug_Target_8_Theoretical_pI:
5.41

# Drug_Target_8_Transmembrane_Regions:
None

# Drug_Target_9_Cellular_Location:
Not Available

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_9_Essentiality:
Non-Essential

# Drug_Target_9_GenAtlas_ID:
Not Available

# Drug_Target_9_GenBank_ID_Gene:
M73842

# Drug_Target_9_GenBank_ID_Protein:
149211

# Drug_Target_9_GeneCard_ID:
Not Available

# Drug_Target_9_Gene_Name:
budB

# Drug_Target_9_Gene_Sequence:
>1680 bp
ATGGACAAACAGTATCCGGTACGCCAGTGGGCGCACGGCGCCGATCTCGTCGTCAGTCAG
CTGGAAGCTCAGGGAGTACGCCAGGTGTTCGGCATCCCCGGCGCCAAAATCGACAAGGTC
TTTGATTCACTGCTGGATTCCTCCATTCGCATTATTCCGGTACGCCACGAAGCCAACGCC
GCATTTATGGCCGCCGCCGTCGGACGCATTACCGGCAAAGCGGGCGTGGCGCTGGTCACC
TCCGGTCCGGGCTGTTCCAACCTGATCACCGGCATGGCCACCGCGAACAGCGAAGGCGAC
CCGGTGGTGGCCCTGGGCGGCGCGGTAAAACGCGCCGATAAAGCGAAGCAGGTCCACCAG
AGTATGGATACGGTGGCGATGTTCAGCCCGGTCACCAAATACGCCATCGAGGTGACGGCG
CCGGATGCGCTGGCGGAAGTGGTCTCCAACGCCTTCCGCGCCGCCGAGCAGGGCCGGCCG
GGCAGCGCGTTCGTTAGCCTGCCGCAGGATGTGGTCGATGGCCCGGTCAGCGGCAAAGTG
CTGCCGGCCAGCGGGGCCCCGCAGATGGGCGCCGCGCCGGATGATGCCATCGACCAGGTG
GCGAAGCTTATCGCCCAGGCGAAGAACCCGATCTTCCTGCTCGGCCTGATGGCCAGCCAG
CCGGAAAACAGCAAGGCGCTGCGCCGTTTGCTGGAGACCAGCCATATTCCAGTCACCAGC
ACCTATCAGGCCGCCGGAGCGGTGAATCAGGATAACTTCTCTCGCTTCGCCGGCCGGGTT
GGGCTGTTTAACAACCAGGCCGGGGACCGTCTGCTGCAGCTCGCCGACCTGGTGATCTGC
ATCGGCTACAGCCCGGTGGAATACGAACCGGCGATGTGGAACAGCGGCAACGCGACGCTG
GTGCACATCGACGTGCTGCCCGCCTATGAAGAGCGCAACTACACCCCGGATGTCGAGCTG
GTGGGCGATATCGCCGGCACTCTCAACAAGCTGGCGCAAAATATCGATCATCGGCTGGTG
CTCTCCCCGCAGGCGGCGGAGATCCTCCGCGACCGCCAGCACCAGCGCGAGCTGCTGGAC
CGCCGCGGCGCGCAGCTCAACCAGTTTGCCCTGCATCCCCTGCGCATCGTTCGCGCCATG
CAGGATATCGTCAACAGCGACGTCACGTTGACCGTGGACATGGGCAGCTTCCATATCTGG
ATTGCCCGCTACCTGTACACGTTCCGCGCCCGTCAGGTGATGATCTCCAACGGCCAGCAG
ACCATGGGCGTCGCCCTGCCCTGGGCTATCGGCGCCTGGCTGGTCAATCCTGAGCGCAAA
GTGGTCTCCGTCTCCGGCGACGGCGGCTTCCTGCAGTCGAGCATGGAGCTGGAGACCGCC
GTCCGCCTGAAAGCCAACGTGCTGCATCTTATCTGGGTCGATAACGGCTACAACATGGTC
GCTATCCAGGAAGAGAAAAAATATCAGCGCCTGTCCGGCGTCGAGTTTGGGCCGATGGAT
TTTAAAGCCTATGCCGAATCCTTCGGCGCGAAAGGGTTTGCCGTGGAAAGCGCCGAGGCG
CTGGAGCCGACCCTGCGCGCGGCGATGGACGTCGACGGCCCGGCGGTAGTGGCCATCCCG
GTGGATTATCGCGATAACCCGCTGCTGATGGGCCAGCTGCATCTGAGTCAGATTCTGTAA

# Drug_Target_9_General_Function:
Amino acid transport and metabolism

# Drug_Target_9_General_References:
1644303	Peng HL, Wang PY, Wu CM, Hwang DC, Chang HY: Cloning, sequencing and heterologous expression of a Klebsiella pneumoniae gene encoding an FAD-independent acetolactate synthase. Gene. 1992 Aug 1;117(1):125-30.

# Drug_Target_9_HGNC_ID:
Not Available

# Drug_Target_9_HPRD_ID:
Not Available

# Drug_Target_9_ID:
2786

# Drug_Target_9_Locus:
Not Available

# Drug_Target_9_Molecular_Weight:
60339

# Drug_Target_9_Name:
Acetolactate synthase, catabolic

# Drug_Target_9_Number_of_Residues:
559

# Drug_Target_9_PDB_ID:
1OZH

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
PF00205	TPP_enzyme_M
PF02775	TPP_enzyme_C
PF02776	TPP_enzyme_N

# Drug_Target_9_Protein_Sequence:
>Acetolactate synthase, catabolic
MDKQYPVRQWAHGADLVVSQLEAQGVRQVFGIPGAKIDKVFDSLLDSSIRIIPVRHEANA
AFMAAAVGRITGKAGVALVTSGPGCSNLITGMATANSEGDPVVALGGAVKRADKAKQVHQ
SMDTVAMFSPVTKYAIEVTAPDALAEVVSNAFRAAEQGRPGSAFVSLPQDVVDGPVSGKV
LPASGAPQMGAAPDDAIDQVAKLIAQAKNPIFLLGLMASQPENSKALRRLLETSHIPVTS
TYQAAGAVNQDNFSRFAGRVGLFNNQAGDRLLQLADLVICIGYSPVEYEPAMWNSGNATL
VHIDVLPAYEERNYTPDVELVGDIAGTLNKLAQNIDHRLVLSPQAAEILRDRQHQRELLD
RRGAQLNQFALHPLRIVRAMQDIVNSDVTLTVDMGSFHIWIARYLYTFRARQVMISNGQQ
TMGVALPWAIGAWLVNPERKVVSVSGDGGFLQSSMELETAVRLKANVLHLIWVDNGYNMV
AIQEEKKYQRLSGVEFGPMDFKAYAESFGAKGFAVESAEALEPTLRAAMDVDGPAVVAIP
VDYRDNPLLMGQLHLSQIL

# Drug_Target_9_Reaction:
2 pyruvate = 2-acetolactate + CO2

# Drug_Target_9_Signals:
None

# Drug_Target_9_Specific_Function:
2 pyruvate = 2-acetolactate + CO(2)

# Drug_Target_9_SwissProt_ID:
P27696

# Drug_Target_9_SwissProt_Name:
ILVB_KLEPN

# Drug_Target_9_Synonyms:
ALS
EC 2.2.1.6

# Drug_Target_9_Theoretical_pI:
5.99

# Drug_Target_9_Transmembrane_Regions:
None

#END_DRUGCARD DB01987
